ArticleScientific reports2019

Clinical utility of androgen receptor gene aberrations in circulating cell-free DNA as a biomarker for treatment of castration-resistant prostate cancer.

Takayuki Sumiyoshi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.